Fennec Pharmaceuticals (FENC) Earnings
|
Expand Research on FENC
| Next EPS Date | 8/6/26 | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | -211.3% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +5.4% | Normal Earnings Time | N/A |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
8/6/26  |
Q226 | N/A | $0.01 | N/A | N/A | $16.62M | N/A | N/A | N/A | ||
| 5/14/26 | Q126 | $0.01 | -$0.04 | +$0.05 | $15.11M | $14.65M | N/A |  | | Details | |
| 5/7/26 |
Q126 | N/A | -$0.04 | N/A | N/A | $14.65M | N/A | N/A | N/A | ||
| 3/24/26 | Q425 | -$0.17 | $0.03 | -$0.20 | $13.77M | $14.56M | N/A | | | Details | |
| 11/13/25 | Q325 | -$0.02 | $0.07 | -$0.09 | $12.5M | $13.37M | N/A | | | Details | |
| 11/11/25 |
Q325 | N/A | $0.07 | N/A | N/A | $13.37M | N/A | N/A | N/A | ||
| 11/10/25 |
Q325 | N/A | $0.07 | N/A | N/A | $13.37M | N/A | N/A | N/A | ||
| 11/7/25 |
Q325 | N/A | $0.07 | N/A | N/A | $13.37M | N/A | N/A | N/A |
